Celeris Therapeutics Company

Harnessing deep learning and lab automation to accelerate drug discovery in targeted protein degradation.
Technology: Biotechnology, Information Technology, Life Science, Pharmaceutical
Industry: AI, Early Drug Development, Preclinical Development, United States
Headquarters: Menlo Park, California, United States
Founded Date: 2021-01-01
Employees Number: 11-50
Funding Status: Seed
Investors Number: 5
Total Funding: 4000000
Last Funding Date: 2022-02-10
Last Funding Type: Seed

Visit Website
hi@celeristx.com
https://twitter.com/celeristx
Register and Claim Ownership